MedPath

Childhood study on respiratory pathogens from induced sputum

Recruiting
Conditions
'lower respiratory tract infections'
'lung infection'
10024970
Registration Number
NL-OMON35654
Lead Sponsor
Jeroen Bosch Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Tachypnea combined with at least one of: elevated body temperature, cough, dyspnea or abdominal pain

Exclusion Criteria

- Acute exacerbation of asthma in the last 4 weeks. This is defined as requiring systemic coricosteroids, hospital admission and/or use of ß-sympaticomimetics >400 µg per day
- Oxygen saturation < 92% without oxygen therapy or severely ill impression
- Anatomical abnormalities of the respiratory tract presenting with inspiratory stridor
- Use of β-blockers, diuretics or theophylline

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The quality of induced sputum, defined as <25 squamous cells and >25 leukocytes<br /><br>per visual field under light microscopy.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To identify bacterial and viral pathogens of lower respiratory tract infections.<br /><br><br /><br>To determine the practical applicability of sputum induction in general<br /><br>pediatric practice.<br /><br><br /><br>To determine the prevalence of Coxiella burnetii infections (Q fever) in<br /><br>children with lower respiratory tract infections.<br /><br><br /><br>To determine the prevalence of Influenza A type H1N1-infections in children<br /><br>with lower respiratory tract infections.</p><br>
© Copyright 2025. All Rights Reserved by MedPath